Rare diseases
Investigational molecules
Locations
Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
BelgiumA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
BelgiumA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
BelgiumA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
AustriaStudy of depemokimab to improve airway function in patients with type 2 eosinophilic asthma
BelgiumA Study of Depemokimab and Prednisolone in Adults with Hypereosinophilic Syndrome (HES)
BelgiumStudy on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma
CzechiaStudy on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis
AustriaStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
